Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
April 2, 2007

Roche Strengthens Antibody Research with $56.5M Acquisition

  • Roche paid $56.5 million for antibody technology company Therapeutic Human Polyclonals (THP). The company reports that the acquisition strengthens its expertise in therapeutic antibody research.

    Roche plans to fully integrate THP into the Roche Pharma Center of Excellence for Protein Research organization in Penzberg, Germany.

    A California-based company with a subsidiary in Germany, THP is focused on research in human antibody technologies. The company has developed a transgenic mammalian platform to create human antibodies. Roche reports that this technology will enable it to generate monoclonal and polyclonal antibody therapeutics with enhanced efficacy.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.